Plasma cell maturity as a predictor of prognosis in multiple myeloma. [electronic resource]
- Medical oncology (Northwood, London, England) Aug 2016
- 87 p. digital
Publication Type: Journal Article
1559-131X
10.1007/s12032-016-0803-3 doi
Adult Aged Aged, 80 and over Antineoplastic Agents--therapeutic use Biomarkers, Tumor--analysis Female Flow Cytometry Humans Immunophenotyping Integrin alpha5--analysis Kaplan-Meier Estimate Male Middle Aged Multiple Myeloma--drug therapy Neoplasm Proteins--analysis Plasma Cells--pathology Prognosis Proportional Hazards Models Retrospective Studies